MEDIA RELEASE, 4 May 2017: A TPP without the US would lock in all the deal’s most damaging and politically controversial clauses on stronger medicine and copyright monopolies and investor rights to sue governments while delivering almost no additional market access, AFTINET Convener Patricia Ranald said today. Read more.
Trans-Pacific Partnership Agreement
26 April 2017: Trump ditched the TPP but that doesn’t mean he wants fair trade. In fact, his trade agency is attacking other countries’ public health initiatives - such as efforts to promote breastfeeding - calling them “barriers to trade” which should be eliminated. Read more from Public Citizen
17 March 2017: Representatives from all TPP countries except the US missed an opportunity to strive for fairer trade deals when they praised the dead TPP in a statement following a meeting in Viña del Mar, Chile.
The meeting was held on the sidelines of a broader meeting on Integration Initiatives in the Asia-Pacific region including non-TPP countries China, Korea and the US.
In praising the TPP, leaders ignored calls for fairer trade deals from civil society organisations from around the world.
MEDIA RELEASE, 16 March 2017: Representatives from all TPP countries except the US missed an opportunity to strive for fairer trade deals when they praised the dead TPP in a statement following a meeting today in Viña del Mar, Chile.
15 March 2017: Chilean community organisations have united to protest the TPP and the corporate agenda of regional trade deals as trade ministers meet in Viña del Mar this week to discuss the post-TPP future.
MEDIA RELEASE, March 9 2017: Two hundred organisations from 15 countries have urged trade ministers meeting in Chile next week not to use the failed TPP as a model for future agreements.
20 February 2017: US President Trump says countries like Australia are “freeloading” because our government regulates medicine prices through the Pharmaceutical Benefits Scheme (PBS).
The PBS is a vital part of Australia’s health system because it helps to ensure lifesaving medicines are affordable and accessible.
At a meeting with pharmaceutical companies in January, Mr Trump said: